Education and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.
2025 · 4th Quarter (Oct 1 - Dec 31)
SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS
Filed by W STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Termination
- Posted
- Jan 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- W STRATEGIES, LLC
- Filing UUID
- 16f2199d-849f-4ccc-8080-b0ec44cbf6e4
- Termination date
- Dec 31, 2025
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.